Paul E. Floreancig

5.0k total citations
121 papers, 4.1k citations indexed

About

Paul E. Floreancig is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Paul E. Floreancig has authored 121 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Organic Chemistry, 33 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Paul E. Floreancig's work include Synthetic Organic Chemistry Methods (61 papers), Asymmetric Synthesis and Catalysis (31 papers) and Catalytic C–H Functionalization Methods (27 papers). Paul E. Floreancig is often cited by papers focused on Synthetic Organic Chemistry Methods (61 papers), Asymmetric Synthesis and Catalysis (31 papers) and Catalytic C–H Functionalization Methods (27 papers). Paul E. Floreancig collaborates with scholars based in United States, China and Japan. Paul E. Floreancig's co-authors include Lei Liu, Wangyang Tu, Hyung Hoon Jung, Shuangyi Wan, Danielle L. Aubele, GuangRong Peh, Youwei Xie, Jason C. Rech, Michael E. Green and Dane J. Clausen and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Angewandte Chemie International Edition.

In The Last Decade

Paul E. Floreancig

116 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul E. Floreancig United States 39 3.3k 851 432 373 334 121 4.1k
Jun’ichi Uenishi Japan 33 3.3k 1.0× 774 0.9× 532 1.2× 477 1.3× 313 0.9× 176 3.8k
Hisahiro Hagiwara Japan 31 2.7k 0.8× 701 0.8× 362 0.8× 330 0.9× 279 0.8× 199 3.6k
Gloria Rassu Italy 36 3.8k 1.2× 1.2k 1.5× 423 1.0× 250 0.7× 202 0.6× 116 4.4k
Shuji Akai Japan 40 3.8k 1.1× 1.3k 1.5× 608 1.4× 147 0.4× 225 0.7× 208 4.9k
Soo Y. Ko South Korea 24 2.5k 0.8× 1.2k 1.4× 337 0.8× 286 0.8× 264 0.8× 54 3.2k
Giovanni Casiraghi Italy 37 4.4k 1.3× 1.4k 1.6× 495 1.1× 275 0.7× 361 1.1× 173 5.3k
Oljan Repič Switzerland 33 2.7k 0.8× 1.1k 1.3× 640 1.5× 244 0.7× 325 1.0× 147 3.5k
P. L. Fuchs United States 40 4.7k 1.4× 1.7k 2.0× 356 0.8× 669 1.8× 366 1.1× 234 6.1k
Tohru Fukuyama Japan 42 3.9k 1.2× 1.4k 1.6× 340 0.8× 222 0.6× 512 1.5× 83 4.8k
Kay M. Brummond United States 34 3.2k 1.0× 746 0.9× 325 0.8× 171 0.5× 224 0.7× 89 3.8k

Countries citing papers authored by Paul E. Floreancig

Since Specialization
Citations

This map shows the geographic impact of Paul E. Floreancig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Floreancig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Floreancig more than expected).

Fields of papers citing papers by Paul E. Floreancig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Floreancig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Floreancig. The network helps show where Paul E. Floreancig may publish in the future.

Co-authorship network of co-authors of Paul E. Floreancig

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. Floreancig. A scholar is included among the top collaborators of Paul E. Floreancig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. Floreancig. Paul E. Floreancig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Floreancig, Paul E., et al.. (2025). Strategy‐Level Prodrug Synthesis. Chemistry - A European Journal. 31(33). e202501115–e202501115.
2.
Deiters, Alexander, et al.. (2025). Difunctional oxidatively cleavable alkenyl boronates: application to cellular peroxide sensing from a fluorophore–quencher pair. Chemical Communications. 61(16). 3375–3378. 2 indexed citations
3.
Deiters, Alexander, et al.. (2024). Potent and Selective Oxidatively Labile Ether‐Based Prodrugs through Late‐Stage Boronate Incorporation. Angewandte Chemie International Edition. 63(40). e202409229–e202409229. 7 indexed citations
6.
Yang, Fei, et al.. (2018). Copper-catalyzed oxidative cross-dehydrogenative coupling of 2H-chromenes and terminal alkynes. Organic & Biomolecular Chemistry. 16(28). 5144–5149. 18 indexed citations
7.
Morales‐Rivera, Cristian A., Paul E. Floreancig, & Peng Liu. (2017). Predictive Model for Oxidative C–H Bond Functionalization Reactivity with 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone. Journal of the American Chemical Society. 139(49). 17935–17944. 72 indexed citations
8.
Xie, Youwei & Paul E. Floreancig. (2014). Heterocycle Synthesis Based on Allylic Alcohol Transposition Using Traceless Trapping Groups. Angewandte Chemie International Edition. 53(19). 4926–4929. 33 indexed citations
9.
Cui, Yubo, et al.. (2013). Bimolecular coupling reactions through oxidatively generated aromatic cations: scope and stereocontrol. Tetrahedron. 69(36). 7618–7626. 42 indexed citations
10.
Mosey, R. Adam & Paul E. Floreancig. (2012). Isolation, biological activity, synthesis, and medicinal chemistry of the pederin/mycalamide family of natural products. Natural Product Reports. 29(9). 980–980. 64 indexed citations
11.
Mosey, R. Adam & Paul E. Floreancig. (2012). Versatile approach to α-alkoxy carbamate synthesis and stimulus-responsive alcohol release. Organic & Biomolecular Chemistry. 10(39). 7980–7980. 32 indexed citations
12.
Liu, Lei & Paul E. Floreancig. (2010). Stereoselective Synthesis of Tertiary Ethers through Geometric Control of Highly Substituted Oxocarbenium Ions. Angewandte Chemie International Edition. 49(34). 5894–5897. 67 indexed citations
13.
Wu, Fanghui, Michael E. Green, & Paul E. Floreancig. (2010). Total Synthesis of Pederin and Analogues. Angewandte Chemie International Edition. 50(5). 1131–1134. 25 indexed citations
14.
Floreancig, Paul E.. (2009). Highly Convergent Synthesis of Peluroside A. Angewandte Chemie International Edition. 48(42). 7736–7739. 6 indexed citations
15.
Jung, Hyung Hoon & Paul E. Floreancig. (2009). Mechanistic analysis of oxidative C–H cleavages using inter- and intramolecular kinetic isotope effects. Tetrahedron. 65(52). 10830–10836. 79 indexed citations
16.
Green, Michael E., Jason C. Rech, & Paul E. Floreancig. (2008). Total Synthesis of Theopederin D. Angewandte Chemie International Edition. 47(38). 7317–7320. 42 indexed citations
17.
Jung, Hyung Hoon, et al.. (2007). Oxidative Cleavage in the Construction of Complex Molecules: Synthesis of the Leucascandrolide A Macrolactone. Angewandte Chemie International Edition. 46(44). 8464–8467. 74 indexed citations
18.
Aubele, Danielle L., Shuangyi Wan, & Paul E. Floreancig. (2005). Total Synthesis of (+)‐Dactylolide through an Efficient Sequential Peterson Olefination and Prins Cyclization Reaction. Angewandte Chemie International Edition. 44(22). 3485–3488. 129 indexed citations
19.
Sofia, Michael J., Paul E. Floreancig, Stephen Baker, et al.. (1997). The Discovery of LY293111, a Novel, Potent and Orally Active Leukotriene B4 Receptor Antagonist of the Biphenylphenol Class. Advances in experimental medicine and biology. 400A. 381–386. 7 indexed citations
20.
Sofia, Michael J., Paul E. Floreancig, Nicholas J. Bach, et al.. (1993). o-Phenylphenols: potent and orally active leukotriene B4 receptor antagonists. Journal of Medicinal Chemistry. 36(24). 3978–3981. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026